Ca and atherosclerosis.
D000368:Aged; D000375:Aging; D000818:Animals; D001011:Aorta / Q000378:metabolism; D001158:Arteries / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology*; D001847:Bone Diseases / Q000150:complications; D002114:Calcinosis / Q000139:chemically induced / Q000150:complications*; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D051381:Rats; D012306:Risk
D002121:Calcium Channel Blockers; D006887:Hydroxycholecalciferols; D009543:Nifedipine; D002118:Calcium; C008088:alfacalcidol